药物反应代谢物诱导的肝毒性:综合性综述
Piyush Mahajan1, Mahesh Palkar2, Ravindra Babu Pingili3
1Department of Pharmaceutical Quality Assurance, SVKM's NMIMS School of Pharmacy and Technology Management, Shirpur, Maharashtra, India.
Toxicology mechanisms and methods
|March 20, 2024
概括
药物诱导性肝毒性 (DILT) 是急性肝衰竭的主要原因之一. 本综述强调了通过有毒代谢物和涉及的酶引起DILT的药物,有助于开发更安全的药物.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 生物化学 生物化学
背景情况:
- 药物诱导性肝毒性 (DILT) 是美国严重肝病和急性肝衰竭的重要原因.
- 许多药物,补充剂和异生菌可以引起DILT,导致肝功能测试异常.
- 肝毒性可以由药物直接诱导,也可以通过药物的有毒代谢产物间接诱导.
研究的目的:
- 审查那些通过有毒代谢物间接引起肝毒性的药物.
- 确定参与这些有毒代谢物的形成的关键酶.
- 为开发无肝毒药品提供信息.
主要方法:
- 对通过有毒代谢物引起DILT的药物的文献综述.
- 识别和讨论介导有毒代谢物形成的酶.
- 对促进药物诱导肝毒性代谢途径的分析.
主要成果:
- 大约有18种药物被确定通过有毒代谢物引起肝毒性.
- 涉及的关键酶包括细胞染色体P-450 (CYP),酒精氧化酶,尿素二酸盐 (UDP) - 葡萄糖转酶等.
- 了解这些代谢途径对于预测和预防DILT至关重要.
结论:
- 形成有毒代谢物的药物对肝脏健康造成重大关注.
- 像CYP这样的酶在产生肝毒性化合物方面发挥着关键作用.
- 准这些酶可能会导致更安全的药物开发和减少DILT发病率.
相关概念视频
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
199
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
199
Toxic Reactions: Overview
972
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
972
Drug Metabolism: Phase I Reactions
3.3K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
3.3K
Drug Metabolism: Phase II Reactions
3.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.8K
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
196
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
196
Phase I Oxidative Reactions: Overview
270
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
270


